About Technology Issues FAQ

Links

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.